Pharmacy Times

AUGUST 7, 2025

Methods Patients aged 18 to 59 years with t-AML or AML-MRC treated with CPX-351 or 7+3 as induction chemotherapy between 2015 and 2022 at 3 National Cancer Institute–designated cancer centers were included. Study Design Retrospective, multicenter, observational cohort study. Author Disclosures Brian A.

Chemotherapy

Pharmacy Times

JULY 3, 2025

I think it’ll be chemotherapy—maybe their cells being given outpatient—and then, as we hit their hardest time or their highest risk for either febrile neutropenia or mucositis or even some of the toxicities from the chemotherapy, we have them inpatient until we feel comfortable, and then transition it so that it could be all outpatient.

Specialty Pharmacies

Pharmaceutical Technology

JULY 4, 2025

Go deeper with GlobalData Reports LOA and PTSR Model - Denosumab Biosimilar in Bone Metastasis Reports LOA and PTSR Model - Denosumab Biosimilar in Chemotherapy Effects Data Insights The gold standard of business intelligence. By inhibiting RANKL, denosumab hampers the bone degradation process, bolstering bone density and strength.

Chemotherapy

Pharmaceutical Technology

JULY 7, 2025

Akeega has been approved in Europe for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in combination with steroid hormone prednisolone since 2023. J&J is now attempting to widen the drug’s application to patients with metastatic hormone-sensitive prostate cancer (mHSPC).

Labelling

Pharmaceutical Technology

JULY 3, 2025

Dizal has received US Food and Drug Administration (FDA) approval for Zegfrovy (sunvozertinib) to treat adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations (exon20ins), following progression on or after receiving platinum-based chemotherapy.

FDA

Pharmaceutical Technology

JUNE 5, 2023

In results presented at the ongoing American Society of Clinical Oncology (ASCO) Annual Meeting , Summit reported an overall response rate (ORR) of 67% in NSCLC patients with squamous histology treated with its lead drug ivonescimab plus chemotherapy. The treatment had an acceptable safety profile in combination with chemotherapy.

Chemotherapy

Hospital Pharmacy Europe

DECEMBER 18, 2023

4,5 Polypharmacy – daily use of five or more drugs – is common in these patients and increases the risk of DRPs, which can result in adverse outcomes such as postoperative complications, chemotherapy toxicities and functional decline. 10,11 This can be due to side effects of chemotherapy or the addition of certain supportive care medications.

Chemotherapy

The Checkup by Singlecare

NOVEMBER 28, 2023

Causes of neuropathy can also include autoimmune diseases like rheumatoid arthritis, nutrient deficiencies, medication toxicity (such as chemotherapy), genetics, and age-related changes, says Dr. Machemehl. Multiple sclerosis is a nervous system disorder that often causes toe numbness. appeared first on The Checkup.

Chemotherapy

The Thyroid Pharmacist

SEPTEMBER 20, 2024

Chemotherapy agents: Chemotherapy agents can lead to constipation in a variety of ways such as slowing the movements of the intestinal tract or creating inflammation that disrupts digestive function. Accessed June 6, 2023. Accessed June 6, 2023. April 2023. Accessed June 6, 2023. Accessed June 6, 2023.

Health and Personal Care Stores

The Checkup by Singlecare

JANUARY 23, 2024

It is known as an antineoplastic (chemotherapy) agent, a disease-modifying antirheumatic drug ( DMARD ), and an immunosuppressant agent. Methotrexate has distinct mechanisms of action for its use as chemotherapy versus immunosuppression in autoimmune diseases.

Adverse Reactions

The Checkup by Singlecare

OCTOBER 27, 2023

How to minimize amoxicillin-potassium clavulanate interactions Your best bet to avoid drug-drug interactions involving amoxicillin-potassium clavulanate is to communicate well with your medical providers.

Adverse Reactions

ISPE

MAY 10, 2023

SPuMoNI: Enhancing Pharma Data Quality through Smart Technologies Trudy Patterson Wed, 05/10/2023 - 09:25 Features May / June 2023 SPuMoNI: Enhancing Pharma Data Quality through Smart Technologies Mariola Mier David Cerrai, Ph.D. Mexican Governor: Cancer Children Given Water Instead of Chemotherapy.” Chis, Ph.D. 30 June 2016.

Chemotherapy

Pharmaceutical Technology

JUNE 13, 2023

Ferring plans to begin Adstiladrin production in the H2 2023, as part of an initial rollout in the US. Common treatment options for the condition include bladder removal surgery, chemotherapy and/or administration of the BCG vaccine in the bladder. The company aims to then increase supplies in 2024.

FDA

The Checkup by Singlecare

JANUARY 12, 2024

Therefore, any onset of symptoms should be managed by immediate communication with a healthcare professional. Cleveland Clinic (2023). Ondansetron is available as an injection, an oral solution, an oral tablet, and an orally-disintegrating tablet. Long QT Syndrome (LQTS).

Mayo Clinic

Pharmaceutical Technology

MARCH 29, 2023

AlgoTx remains on track to start enrolling subjects of a Phase II study of its compound ATX01 for the rare condition erythromelalgia in Q2 2023, says CEO Stéphane Thiroloix. Stéphane Thiroloix, CEO of AlgoTx Alongside erythromelalgia, the company is testing ATX01 in a Phase II study in chemotherapy-induced peripheral neuropathy (CIPN).

Chemotherapy

The Checkup by Singlecare

FEBRUARY 8, 2024

While it can be used to manage many mental health conditions, including bipolar disorder and schizophrenia , it also plays a role in the prevention and treatment of chemotherapy-induced nausea and vomiting.

Mayo Clinic

The Checkup by Singlecare

OCTOBER 27, 2023

ACS , 2023) Breast cancer accounts for about 30% of new female cancers each year. ( ACS , 2023) The risk for breast cancer in women increases nearly double if their mother, sister, or daughter has had the same cancer. Breastcancer.org , 2023) Breast cancer occurs mostly in women and rarely affects men.

Chemotherapy

The Checkup by Singlecare

NOVEMBER 13, 2023

According to the CDC , treatment includes surgery, chemotherapy, radiation therapy, targeted therapy, or a combination of these treatments. Pulmonary hypertension Pulmonary hypertension is a condition that develops from increased blood pressure in the blood vessels in the lungs.

Mayo Clinic

NF2 BioSolutions

MAY 19, 2025

Surgery, radiotherapy & the chemotherapy type drugs are all invasive interventions with serious side effects. Also, my experience in 2023 motivated me. How frequently did you need to visit the study site or communicate with the research team? I had fantastic communication with Hannah from the research team.

Communication